{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:29:23Z","timestamp":1794029363813,"version":"4.8.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jocn.2022.11.016","type":"journal-article","created":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T18:10:22Z","timestamp":1670523022000},"page":"54-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Peripheral high levels of CRP predict progression from normal cognition to dementia: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"107","author":[{"given":"Siwei","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhizhong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingqing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingnian","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinzhou","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2022.11.016_b0005","unstructured":"Zeisel J, Bennett K, Fleming R (2020) World Alzheimer Report 2020: Design, dignity, dementia: Dementia-related design and the built environment."},{"key":"10.1016\/j.jocn.2022.11.016_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cger.2009.12.002","article-title":"Healthy brain aging: a road map","volume":"26","author":"Desai","year":"2010","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.jocn.2022.11.016_b0015","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/2040622311399145","article-title":"Cognitive dysfunction with aging and the role of inflammation","volume":"2","author":"Simen","year":"2011","journal-title":"Therapeutic Advances in Chronic Disease"},{"issue":"Suppl 1","key":"10.1016\/j.jocn.2022.11.016_b0020","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1093\/gerona\/glu057","article-title":"Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases","volume":"69","author":"Franceschi","year":"2014","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jocn.2022.11.016_b0025","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.autrev.2018.04.001","article-title":"Inflammation and dementia: Using rheumatoid arthritis as a model to develop treatments?","volume":"17","author":"Mason","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jocn.2022.11.016_b0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23010386","article-title":"The Role of Inflammation in Retinal Neurodegeneration and Degenerative Diseases","volume":"23","author":"Kaur","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jocn.2022.11.016_b0035","doi-asserted-by":"crossref","unstructured":"Katsnelson A, De Strooper B, Zoghbi HY (2016) Neurodegeneration: From cellular concepts to clinical applications. Science translational medicine 8:364ps18. https:\/\/doi.org\/10.1126\/scitranslmed.aal2074.","DOI":"10.1126\/scitranslmed.aal2074"},{"key":"10.1016\/j.jocn.2022.11.016_b0040","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1532-5415.2007.01159.x","article-title":"Systemic markers of inflammation and cognitive decline in old age","volume":"55","author":"Schram","year":"2007","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jocn.2022.11.016_b0045","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.clinbiochem.2019.04.001","article-title":"Neuro-inflammation and anti-inflammatory treatment options for Alzheimer's disease","volume":"72","author":"Ozben","year":"2019","journal-title":"Clin Biochem"},{"key":"10.1016\/j.jocn.2022.11.016_b0050","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2018101064","article-title":"Systemic inflammation impairs microglial A\u03b2 clearance through NLRP3 inflammasome","volume":"38","author":"Tejera","year":"2019","journal-title":"EMBO J"},{"key":"10.1016\/j.jocn.2022.11.016_b0055","doi-asserted-by":"crossref","first-page":"908","DOI":"10.2174\/1570159X18666201111104509","article-title":"Glia-Driven Neuroinflammation and Systemic Inflammation in Alzheimer's Disease","volume":"19","author":"Hashioka","year":"2021","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.jocn.2022.11.016_b0060","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00011-019-01269-1","article-title":"Regulation of C-reactive protein conformation in inflammation","volume":"68","author":"Yao","year":"2019","journal-title":"Inflammation Res"},{"key":"10.1016\/j.jocn.2022.11.016_b0065","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bbi.2018.02.013","article-title":"Rethinking IL-6 and CRP: Why they are more than inflammatory biomarkers, and why it matters","volume":"70","author":"Del Giudice","year":"2018","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.jocn.2022.11.016_b0070","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jocn.2022.11.016_b0075","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1001\/archneurol.2009.308","article-title":"Association of C-reactive protein with cognitive impairment","volume":"67","author":"Noble","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jocn.2022.11.016_b0080","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1212\/01.WNL.0000073620.42047.D7","article-title":"Inflammatory markers and cognition in well-functioning African-American and white elders","volume":"61","author":"Yaffe","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2022.11.016_b0085","doi-asserted-by":"crossref","unstructured":"Tsui A, Richards M, Davis D (2018) Systemic inflammation and modifiable risk factors for cognitive impairment in older persons: Findings from a British birth cohort. Aging medicine (Milton (NSW)) 1:243-8. https:\/\/doi.org\/10.1002\/agm2.12044.","DOI":"10.1002\/agm2.12044"},{"key":"10.1016\/j.jocn.2022.11.016_b0090","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1016\/j.neurobiolaging.2014.05.030","article-title":"Trajectories of inflammatory markers and cognitive decline over 10 years","volume":"35","author":"Metti","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jocn.2022.11.016_b0095","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/gerona\/glu132","article-title":"Interleukin-6 and C-Reactive Protein Levels and 9-Year Cognitive Decline in Community-Dwelling Older Women: The Women's Health and Aging Study II","volume":"70","author":"Palta","year":"2015","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jocn.2022.11.016_b0100","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/gps.1772","article-title":"Markers of inflammation and cognitive decline in an African-Caribbean population","volume":"22","author":"Jordanova","year":"2007","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jocn.2022.11.016_b0105","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/gerona\/63.1.50","article-title":"Inflammation and rate of cognitive change in high-functioning older adults","volume":"63","author":"Alley","year":"2008","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jocn.2022.11.016_b0110","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/jgs.12994","article-title":"Long-term systemic inflammation and cognitive impairment in a population-based cohort","volume":"62","author":"Wichmann","year":"2014","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jocn.2022.11.016_b0115","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.psyneuen.2008.07.006","article-title":"Inflammatory markers and cognitive function in middle-aged adults: the Whitehall II study","volume":"33","author":"Gimeno","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jocn.2022.11.016_b0135","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ana.10265","article-title":"Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia Aging Study","volume":"52","author":"Schmidt","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2022.11.016_b0140","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1212\/01.WNL.0000158281.08946.68","article-title":"Serum inflammatory proteins and cognitive decline in older persons","volume":"64","author":"Dik","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2022.11.016_b0145","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1532-5415.2009.02169.x","article-title":"High levels of serum C-reactive protein are associated with greater risk of all-cause mortality, but not dementia, in the oldest-old: Results from the 90+ study","volume":"57","author":"Kravitz","year":"2009","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jocn.2022.11.016_b0125","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3233\/JAD-2009-1126","article-title":"Systemic inflammation and the risk of Alzheimer's disease and dementia: a prospective population-based study","volume":"18","author":"Sundel\u00f6f","year":"2009","journal-title":"JAD"},{"key":"10.1016\/j.jocn.2022.11.016_b0130","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1212\/WNL.0000000000000665","article-title":"Interleukin-6 and C-reactive protein as predictors of cognitive decline in late midlife","volume":"83","author":"Singh-Manoux","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2022.11.016_b0150","doi-asserted-by":"crossref","unstructured":"Hsu PF, Pan WH, Yip BS, et al (2017) C-Reactive Protein Predicts Incidence of Dementia in an Elderly Asian Community Cohort. Journal of the American Medical Directors Association 18:277.e7-.e11. https:\/\/doi.org\/10.1016\/j.jamda.2016.12.006.","DOI":"10.1016\/j.jamda.2016.12.006"},{"key":"10.1016\/j.jocn.2022.11.016_b0155","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12979-022-00265-0","article-title":"High sensitivity C-reactive protein and glycated hemoglobin levels as dominant predictors of all-cause dementia: a nationwide population-based cohort study","volume":"19","author":"Fan","year":"2022","journal-title":"Immunity & Ageing: I & A"},{"key":"10.1016\/j.jocn.2022.11.016_b0120","unstructured":"Wells GA, Shea B, O\u2019Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Oxford; 2000."},{"key":"10.1016\/j.jocn.2022.11.016_b0160","doi-asserted-by":"crossref","first-page":"15385","DOI":"10.1038\/s41598-019-51673-0","article-title":"Comparative analysis of obesity-related cardiometabolic and renal biomarkers in human plasma and serum","volume":"9","author":"Rajan","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jocn.2022.11.016_b0165","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/ageing\/aft193","article-title":"C-reactive protein, APOE genotype and longitudinal cognitive change in an older population","volume":"43","author":"Lima","year":"2014","journal-title":"Age Ageing"},{"key":"10.1016\/j.jocn.2022.11.016_b0170","doi-asserted-by":"crossref","unstructured":"Walker KA, Gottesman RF, Wu A, et al (2019) Systemic inflammation during midlife and cognitive change over 20 years: The ARIC Study. Neurology 92:e1256-e67. https:\/\/ doi.org\/10.1212\/WNL.0000000000007094.","DOI":"10.1212\/WNL.0000000000007094"},{"key":"10.1016\/j.jocn.2022.11.016_b0175","doi-asserted-by":"crossref","first-page":"e0244612","DOI":"10.1371\/journal.pone.0244612","article-title":"C-reactive protein and risk of cognitive decline: The REGARDS study","volume":"15","author":"Arce Renter\u00eda","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jocn.2022.11.016_b0180","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1172\/JCI200318921","article-title":"C-reactive protein: a critical update","volume":"111","author":"Pepys","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jocn.2022.11.016_b0185","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2022.11.016_b0190","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0140-6736(09)61717-7","article-title":"C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis","volume":"375","author":"Kaptoge","year":"2010","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.jocn.2022.11.016_b0195","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/eurheartj\/eht367","article-title":"Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis","volume":"35","author":"Kaptoge","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jocn.2022.11.016_b0200","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/978-3-030-41769-7_20","article-title":"C-Reactive Protein and Its Structural Isoforms: An Evolutionary Conserved Marker and Central Player in Inflammatory Diseases and Beyond","volume":"94","author":"McFadyen","year":"2020","journal-title":"Subcell Biochem"},{"key":"10.1016\/j.jocn.2022.11.016_b0205","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.1038\/s41598-019-42286-8","article-title":"Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice","volume":"9","author":"Zhao","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jocn.2022.11.016_b0210","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jalz.2016.02.010","article-title":"Neuroinflammation in Alzheimer's disease: Current evidence and future directions","volume":"12","author":"Calsolaro","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jocn.2022.11.016_b0215","doi-asserted-by":"crossref","first-page":"e0136722","DOI":"10.1371\/journal.pone.0136722","article-title":"Baseline Plasma C-Reactive Protein Concentrations and Motor Prognosis in Parkinson Disease","volume":"10","author":"Umemura","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jocn.2022.11.016_b0220","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?","volume":"17","author":"Leng","year":"2021","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.jocn.2022.11.016_b0225","doi-asserted-by":"crossref","first-page":"e183597","DOI":"10.1001\/jamanetworkopen.2018.3597","article-title":"Association of Chronic Low-grade Inflammation With Risk of Alzheimer Disease in ApoE4 Carriers","volume":"1","author":"Tao","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jocn.2022.11.016_b0230","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/jnnp-2018-319148","article-title":"Inflammatory markers in Alzheimer's disease and mild cognitive impairment: a meta-analysis and systematic review of 170 studies","volume":"90","author":"Shen","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2022.11.016_b0235","doi-asserted-by":"crossref","unstructured":"M.N. Haan A.E. Aiello N.A. West et al. C-reactive protein and rate of dementia in carriers and non carriers of Apolipoprotein APOE4 genotype Neurobiology of aging 29 2008 1774 \u201382 doi.org\/10.1016\/j.neurobiolaging.2007.04.020 https:\/\/.","DOI":"10.1016\/j.neurobiolaging.2007.04.020"},{"key":"10.1016\/j.jocn.2022.11.016_b0240","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/aje\/kwg135","article-title":"Refinement of the association of serum C-reactive protein concentration and coronary heart disease risk by correction for within-subject variation over time: the MONICA Augsburg studies, 1984 and 1987","volume":"158","author":"Koenig","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jocn.2022.11.016_b0245","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/jnnp-2017-317134","article-title":"Peripheral inflammation in prodromal Alzheimer's and Lewy body dementias","volume":"89","author":"King","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2022.11.016_b0250","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/gps.5365","article-title":"Prospective longitudinal evaluation of cytokines in mild cognitive impairment due to AD and Lewy body disease","volume":"35","author":"Thomas","year":"2020","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jocn.2022.11.016_b0255","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/ageing\/afm051","article-title":"Serum high sensitivity C-reactive protein and cognitive function in elderly women","volume":"36","author":"Komulainen","year":"2007","journal-title":"Age Ageing"},{"key":"10.1016\/j.jocn.2022.11.016_b0260","doi-asserted-by":"crossref","unstructured":"Gimeno D, Marmot MG, Singh-Manoux A (2008) Inflammatory markers and cognitive function in middle-aged adults: the Whitehall II study. Psychoneuroendocrinology 33:1322-34. https:\/\/ doi.org\/10.1016\/j.psyneuen.2008.07.006.","DOI":"10.1016\/j.psyneuen.2008.07.006"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586822004684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586822004684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:31:49Z","timestamp":1760823109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586822004684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":52,"alternative-id":["S0967586822004684"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2022.11.016","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripheral high levels of CRP predict progression from normal cognition to dementia: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2022.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}